Global Atrial Fibrillation Market – Treatment Types and End-User Facilities
REPORT SYNOPSIS
Atrial Fibrillation (AF) is the most common arrhythmia, which can lead to stroke, peripheral embolization, heart failure and other unfavorable outcomes. While the incidence of AF among the general population has been found to be at about 2.3%-3.4%, this registers a significant increase in patients with pulmonary disease, critical illness or systemic inflammatory response syndrome, with devastating clinical impact. A number of recent epidemiological studies have established a greater risk of AF and new-onset AF among patients with COVID-19, though the results have been quite inconsistent. The literature available thus far has indicated that AF or new-onset AF can have a substantial association with the worst outcomes, viz., mortality, in patients with COVID-19.
Apart from the recent development of COVID-19 and its effect on AF, other factors that increase the risk of this condition include growing worldwide prevalence of obesity and heart diseases. The rise in the number of AF cases is fueling the market for treating this disease, though at the same time posing a crushing burden on the economies of several countries because of the high treatment cost involved.
Research Findings & Coverage
The report analyzes the market for the following key treatment types/sub-types of Atrial Fibrillation:
Atrial Fibrillation (AF) is the most common arrhythmia, which can lead to stroke, peripheral embolization, heart failure and other unfavorable outcomes. While the incidence of AF among the general population has been found to be at about 2.3%-3.4%, this registers a significant increase in patients with pulmonary disease, critical illness or systemic inflammatory response syndrome, with devastating clinical impact. A number of recent epidemiological studies have established a greater risk of AF and new-onset AF among patients with COVID-19, though the results have been quite inconsistent. The literature available thus far has indicated that AF or new-onset AF can have a substantial association with the worst outcomes, viz., mortality, in patients with COVID-19.
Apart from the recent development of COVID-19 and its effect on AF, other factors that increase the risk of this condition include growing worldwide prevalence of obesity and heart diseases. The rise in the number of AF cases is fueling the market for treating this disease, though at the same time posing a crushing burden on the economies of several countries because of the high treatment cost involved.
Research Findings & Coverage
- Global Atrial Fibrillation market is analyzed in this report with respect to treatment type/sub-type, end-user facilities
- The study exclusively analyzes the market size of each treatment type/sub-type and end-user facility of Atrial Fibrillation by all major geographic regions/countries
- Artificial Intelligence Comes to the Fore in Diagnosing and Managing Arrythmias
- Digital Health Technologies Take a Lead in Screening for Atrial Fibrillation (AF)
- Thumb ECGs Playing a Greater Role Atrial Fibrillation Detection
- Revolutionary Catheter Ablation Technologies for AF Take Centerstage
- Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
- Major companies profiled – 19
- The industry guide includes the contact details for 70 companies
The report analyzes the market for the following key treatment types/sub-types of Atrial Fibrillation:
- Non-Pharmacological Treatment
- Catheter Ablation
- Electric Cardioversion
- High Intensity Focused Ultrasound (HIFU)
- Maze Surgery
- Other Ablation Treatments
- Pharmacological Treatment
- Blood Thinners
- Heart Rate Drugs
- Heart Rhythm Drugs
- Ambulatory Surgical Centers
- Cardiac Centers
- Hospitals
- The report reviews, analyzes and projects the global Atrial Fibrillation market for the period 2018-2027 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2022 through 2027 with a special focus on y-o-y growth for 2019, 2020 and 2021
- North America (The United States, Canada and Mexico)
- Europe (France, Germany, Italy, the United Kingdom and Rest of Europe)
- Asia-Pacific (China, India, Japan and Rest of Asia-Pacific)
- Rest of World
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
1.1 Product Outline
1.1.1 An Overview of Atrial Fibrillation
1.1.1.1 Classification of AF
1.1.1.1.1 Paroxysmal (Self-Terminating or Intermittent) Atrial Fibrillation
1.1.1.1.2 Persistent Atrial Fibrillation
1.1.1.1.3 Permanent Atrial Fibrillation
1.1.1.1.4 Lone Atrial Fibrillation
1.1.1.2 Clinical Features
1.1.1.3 Risk factors for Atrial Fibrillation
1.1.1.3.1 Clinical Risk Factors
1.1.1.3.2 Reversible Risk Factors
1.1.1.3.3 Nonmodifiable Factors
1.1.1.3.4 Emerging Risk Factors
1.1.2 Treatment of Atrial Fibrillation (AF)
1.1.2.1 Non-Pharmacological Treatments
1.1.2.1.1 Catheter Ablation
1.1.2.1.2 Electric Cardioversion
1.1.2.1.3 High Intensity Focused Ultrasound (HIFU)
1.1.2.1.4 Maze Surgery
1.1.2.1.5 Other Ablation Treatments
1.1.2.1.5.1 Cryoablation
1.1.2.1.5.2 Microwave Ablation
1.1.2.1.5.3 Radiofrequency Ablation
1.1.2.2 Pharmacological Treatments
1.1.2.2.1 Blood Thinners
1.1.2.2.1.1 Antiplatelet Drugs
1.1.2.2.1.2 Anticoagulants Drugs
1.1.2.2.2 Heart Rate Drugs
1.1.2.2.2.1 Beta-Blockers
1.1.2.2.2.2 Calcium Channel Blockers
1.1.2.2.2.3 Digitalis Glycosides
1.1.2.2.3 Heart Rhythm Drugs
1.1.2.2.3.1 Sodium Channel Blockers
1.1.2.2.3.2 Potassium Channel Blockers
2. AF TREATMENT BY END-USER FACILITIES – MARKET SNAPSHOT
2.1 Ambulatory Surgical Centers
2.2 Cardiac Centers
2.3 Hospitals
3. KEY MARKET TRENDS
3.1 Artificial Intelligence Comes to the Fore in Diagnosing and Managing Arrythmias
3.2 Digital Health Technologies Take a Lead in Screening for Atrial Fibrillation (AF)
3.3 Thumb ECGs Playing a Greater Role Atrial Fibrillation Detection
3.4 Atrial Fibrillation Treated Successfully through Pulsed Field Ablation
3.5 Revolutionary Catheter Ablation Technologies for AF Take Centerstage
4. KEY GLOBAL PLAYERS
Abbott Laboratories (United States)
Atricure, Inc. (United States)
Biosense Webster, Inc. (United States)
Biotronik SE & Co. Kg (Germany)
Boehringer Ingelheim International GmbH (Germany)
Boston Scientific Corporation (United States)
Bristol-Myers Squibb Co. (United States)
Cardiofocus, Inc. (United States)
Cathrx Ltd (Australia)
Medtronic Plc (Ireland)
Osypka AG (Germany)
Pfizer Inc. (United States)
Shanghai Microport Medical (Group) Co Ltd (China)
Siemens Medical Solutions USA, Inc. (United States)
5. KEY BUSINESS & PRODUCT TRENDS
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Acutus Medical’s Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System
Medtronic to Acquire Affera
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation
Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Biosense Webster Announces Completion of Atrial Fibrillation Cases Using Novel HELIOSTAR Balloon Ablation Catheter
New Data & Innovations: Heart Rhythm 2021
BIOTRONIK Expands Range of Peripheral Introducer Sheaths
CardioFocus-Announces-Agreement-to-Acquire-Intellectual-Property-Press-Release.pdf
Late-Breaking Data Shows Abbott's Amplatzer Amulet Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke
Abbott's Amplatzer Amulet Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Abbott Receives European And Canadian Approval For Amplatzer Steerable Delivery Sheath To Optimize Left Atrial Appendage Closure Procedures For People At Risk Of Stroke
Medtronic Receives FDA Expanded Approval for Arctic Front Family of Cardiac Cryoablation Catheters for Initial Use for Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Abbott Introduces Jot Dx Insertable Cardiac Monitor, Designed To Reduce Data Burden And Improve Accurate Diagnosis Of Difficult-To-Detect Abnormal Heart Rhythms
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
New Data & Innovations: Heart Rhythm 2021
BIOTRONIK’s Cardiac Monitor Receives Prestigious Award
Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX Left Atrial Appendage Closure Device
CardioFocus to Exhibit and Present Data Supporting HeartLight X3 System at Heart Rhythm 2021
CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care
Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes
Siemens Healthineers Receives CE Mark for the ACUSON AcuNav Volume ICE Catheter
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate FORCE Sensing Ablation System
Japan Lifeline Finalizes Supply Agreement for Pulsed Electric Field Ablation Catheter for U.S. Market
Acutus Medical Announces FDA Clearance of AcQCross, a Full Suite of Universal Transseptal Crossing Devices
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate FORCE Sensing Ablation System
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
Acutus Medical Receives Vizient Innovative Technology Contract
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
CardioFocus Announces Expanded Partnership With Japan Lifeline
CardioFocus Announces Expanded Distribution Partnership With MicroPort CRM To Include Spain And Portugal
Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation
Acutus Medical Announces CE Mark and European Launch of AcQCross Transseptal System, a Fully Integrated Family of Transseptal Crossing Products
CardioFocus Announces 10,000 Patients Treated Worldwide
First Clinical Implantation of MicroPort Left…
Abbott Introduces Next-Generation 3d Cardiac Mapping Platform In Europe And Australia
The New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy
Acutus Medical Launches AcQBlate Force Sensing Ablation System in Europe
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter
Acutus Medical Announces Pulsed Field Ablation Program and Initial Pre-Clinical Results
Medtronic Gains FDA Clearance, CE Mark for LINQ II Insertable Cardiac Monitor (ICM)
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
Medtronic Micra AV Receives CE Mark
New Alliance Maps the Way in Electrophysiology
CardioFocus Announces US FDA Approval of HeartLight X3 System for the Treatment of Atrial Fibrillation
GE Healthcare and Preventice Solutions Collaborate to Connect the Heart, the Hospital and the Home Seamlessly
Bristol Myers Squibb - The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis
6. GLOBAL MARKET OVERVIEW
6.1 Global Atrial Fibrillation Market Overview by Treatment Type
6.1.1 Global Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
6.1.2 Global Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
6.1.3 Atrial Fibrillation Treatment Type Market Overview by Global Region
6.1.3.1 Non-Pharmacological
6.1.3.1.1 Atrial Fibrillation’s Non-Pharmacological Treatment Sub-Type Market Overview by Global Region
6.1.3.1.1.1 Catheter Ablation
6.1.3.1.1.2 Electric Cardioversion
6.1.3.1.1.3 High Intensity Focused Ultrasound (HIFU)
6.1.3.1.1.4 Maze Surgery
6.1.3.1.1.5 Other Ablation Treatments
6.1.3.2 Pharmacological
6.1.3.2.1 Atrial Fibrillation’s Pharmacological Treatment Sub-Type Market Overview by Global Region
6.1.3.2.1.1 Blood Thinners
6.1.3.2.1.2 Heart Rate Drugs
6.1.3.2.1.3 Heart Rhythm Drugs
6.2 Global Atrial Fibrillation Market Overview by End-User Facility
6.2.1 Atrial Fibrillation End-User Facility Market Overview by Global Region
6.2.1.1 Ambulatory Surgical Centers
6.2.1.2 Cardiac Centers
6.2.1.3 Hospitals
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
7.1 North American Atrial Fibrillation Market Overview by Geographic Region
7.2 North American Atrial Fibrillation Market Overview by Treatment Type
7.2.1 North American Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.2.2 North American Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.3 North American Atrial Fibrillation Market Overview by End-User Facility
7.4 Major Market Players
Abbott Laboratories (United States)
Acutus Medical, Inc. (United States)
Atricure, Inc. (United States)
Biosense Webster, Inc. (United States)
Boston Scientific Corporation (United States)
Bristol-Myers Squibb Co. (United States)
Cardiofocus, Inc. (United States)
GE Healthcare (United States)
Pfizer Inc. (United States)
Siemens Medical Solutions USA, Inc. (United States)
7.5 Country-wise Analysis of North American Atrial Fibrillation Market
7.5.1 The United States
7.5.1.1 United States' Atrial Fibrillation Market Overview by Treatment Type
7.5.1.1.1 United States' Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.1.1.2 United States' Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.1.2 United States' Atrial Fibrillation Market Overview by End-User Facility
7.5.2 Canada
7.5.2.1 Canadian Atrial Fibrillation Market Overview by Treatment Type
7.5.2.1.1 Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.2.1.2 Canadian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.2.2 Canadian Atrial Fibrillation Market Overview by End-User Facility
7.5.3 Mexico
7.5.3.1 Mexican Atrial Fibrillation Market Overview by Treatment Type
7.5.3.1.1 Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.3.1.2 Mexican Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.3.2 Mexican Atrial Fibrillation Market Overview by End-User Facility
8. EUROPE
8.1 European Atrial Fibrillation Market Overview by Geographic Region
8.2 European Atrial Fibrillation Market Overview by Treatment Type
8.2.1 European Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.2.2 European Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.3 European Atrial Fibrillation Market Overview by End-User Facility
8.4 Major Market Players
Acesion Pharma (Denmark)
Afreeze GmbH (Austria)
Biotronik SE & Co. Kg (Germany)
Boehringer Ingelheim International GmbH (Germany)
Medtronic PLC (Ireland)
Osypka AG (Germany)
8.5 Country-wise Analysis of European Atrial Fibrillation Market
8.5.1 France
8.5.1.1 French Atrial Fibrillation Market Overview by Treatment Type
8.5.1.1.1 French Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.1.1.2 French Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.1.2 French Atrial Fibrillation Market Overview by End-User Facility
8.5.2 Germany
8.5.2.1 German Atrial Fibrillation Market Overview by Treatment Type
8.5.2.1.1 German Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.2.1.2 German Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.2.2 German Atrial Fibrillation Market Overview by End-User Facility
8.5.3 Italy
8.5.3.1 Italian Atrial Fibrillation Market Overview by Treatment Type
8.5.3.1.1 Italian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.3.1.2 Italian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.3.2 Italian Atrial Fibrillation Market Overview by End-User Facility
8.5.4 The United Kingdom
8.5.4.1 United Kingdom Atrial Fibrillation Market Overview by Treatment Type
8.5.4.1.1 United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.4.1.2 United Kingdom Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.4.2 United Kingdom Atrial Fibrillation Market Overview by End-User Facility
8.5.5 Rest of Europe
8.5.5.1 Rest of Europe Atrial Fibrillation Market Overview by Treatment Type
8.5.5.1.1 Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.5.1.2 Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.5.2 Rest of Europe Atrial Fibrillation Market Overview by End-User Facility
9. ASIA-PACIFIC
9.1 Asia-Pacific Atrial Fibrillation Market Overview by Geographic Region
9.2 Asia-Pacific Atrial Fibrillation Market Overview by Treatment Type
9.2.1 Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.2.2 Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.3 Asia-Pacific Atrial Fibrillation Market Overview by End-User Facility
9.4 Major Market Players
Cathrx Ltd (Australia)
Japan Lifeline Co. (Japan)
Shanghai Microport Medical (Group) Co Ltd (China)
9.5 Country-wise Analysis of Asia-Pacific Atrial Fibrillation Market
9.5.1 China
9.5.1.1 Chinese Atrial Fibrillation Market Overview by Treatment Type
9.5.1.1.1 Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.1.1.2 Chinese Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.1.2 Chinese Atrial Fibrillation Market Overview by End-User Facility
9.5.2 India
9.5.2.1 Indian Atrial Fibrillation Market Overview by Treatment Type
9.5.2.1.1 Indian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.2.1.2 Indian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.2.2 Indian Atrial Fibrillation Market Overview by End-User Facility
9.5.3 Japan
9.5.3.1 Japanese Atrial Fibrillation Market Overview by Treatment Type
9.5.3.1.1 Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.3.1.2 Japanese Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.3.2 Japanese Atrial Fibrillation Market Overview by End-User Facility
9.5.4 Rest of Asia-Pacific
9.5.4.1 Rest of Asia-Pacific Atrial Fibrillation Market Overview by Treatment Type
9.5.4.1.1 Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.4.1.2 Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.4.2 Rest of Asia-Pacific Atrial Fibrillation Market Overview by End-User Facility
10. REST OF WORLD
10.1 Rest of World Atrial Fibrillation Market Overview by Treatment Type
10.1.1 Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
10.1.2 Rest of World Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
10.2 Rest of World Atrial Fibrillation Market Overview by End-User Facility
PART C: GUIDE TO THE INDUSTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
CHARTS & GRAPHS
PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Atrial Fibrillation Market (2019, 2021, 2022 & 2027) by Geographic Region
Chart 2: Global Non-Pharmacological Treatment of AF Market (2019, 2021, 2022 & 2027) by Sub-Type
Chart 3: Global Pharmacological Treatment of AF Market (2019, 2021, 2022 & 2027) by Sub-Type
Chart 4: Global Atrial Fibrillation Market (2019, 2021, 2022 & 2027) by End-User Facility
Chart 5: Trending of AF Treatment Market (2021 & 2027) in Ambulatory Surgical Centers by Geographic Region
Chart 6: Trending of AF Treatment Market (2021 & 2027) in Cardiac Centers by Geographic Region
Chart 7: Trending of AF Treatment Market (2021 & 2027) in Hospitals by Geographic Region
Chart 8: Global Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 9: Global Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 10: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 11: Global Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 12: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 13: Global Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 14: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 15: Global Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 16: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 17: Global Atrial Fibrillation Catheter Ablation Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 18: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Catheter Ablation Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 19: Global Atrial Fibrillation Electric Cardioversion Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2018, 2021 and 2027 Global Electric Cardioversion Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 21: Global Atrial Fibrillation High Intensity Focused Ultrasound (HIFU) Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2018, 2021 and 2027 Global High Intensity Focused Ultrasound (HIFU) Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 23: Global Atrial Fibrillation Maze Surgery Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2018, 2021 and 2027 Global Maze Surgery Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 25: Global Atrial Fibrillation Other Ablation Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 26: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Other Ablation Treatments Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 27: Global Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Pharmacological Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 29: Global Atrial Fibrillation Blood Thinner Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Blood Thinner Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 31: Global Atrial Fibrillation Heart Rate Drug Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Heart Rate Drug Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 33: Global Atrial Fibrillation Heart Rhythm Drug Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 34: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Heart Rhythm Drug Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 35: Global Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 36: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Chart 37: Global Atrial Fibrillation Market Analysis (2018-2027) in Ambulatory Surgical Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 38: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Ambulatory Surgical Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 39: Global Atrial Fibrillation Market Analysis (2018-2027) in Cardiac Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 40: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Cardiac Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 41: Global Atrial Fibrillation Market Analysis (2018-2027) in Hospitals by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 42: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Hospitals by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
PART B: REGIONAL MARKET PERSPECTIVE
Chart 43: Global Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 44: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
REGIONAL MARKET OVERVIEW
NORTH AMERICA
Chart 45: North American Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 46: North American Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 47: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 48: North American Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 49: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 50: North American Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 51: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 52: North American Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 53: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 54: North American Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 55: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
The United States
Chart 56: United States' Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 57: United States' Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 58: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 59: United States' Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 60: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 61: United States' Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 62: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 63: United States' Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 64: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Canada
Chart 65: Canadian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 66: Canadian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 67: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 68: Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 69: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 70: Canadian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 71: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 72: Canadian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 73: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Mexico
Chart 74: Mexican Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 75: Mexican Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 76: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 77: Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 78: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 79: Mexican Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 80: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 81: Mexican Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 82: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
EUROPE
Chart 83: European Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 84: European Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 85: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe
Chart 86: European Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 87: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 88: European Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 89: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 90: European Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 91: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 92: European Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 93: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
France
Chart 95: French Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 96: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 97: French Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 98: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 99: French Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 100: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 101: French Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 102: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Germany
Chart 103: German Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 104: German Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 105: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 106: German Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 107: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 108: German Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 109: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 110: German Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 111: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Italy
Chart 112: Italian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 113: Italian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 114: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 115: Italian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 116: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 117: Italian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 118: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 119: Italian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 120: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
The United Kingdom
Chart 121: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 122: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 123: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 124: United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 125: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 126: United Kingdom Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 127: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 128: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 129: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Rest of Europe
Chart 130: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 131: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 132: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 133: Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 134: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 135: Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 136: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 137: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 138: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
ASIA-PACIFIC
Chart 139: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 140: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 141: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by Geographic Region – China, India, Japan and Rest of Asia-Pacific
Chart 142: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 143: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 144: Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 145: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 146: Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 147: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 148: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 149: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
China
Chart 150: Chinese Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 151: Chinese Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 152: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 153: Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 154: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 155: Chinese Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 156: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 157: Chinese Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 158: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
India
Chart 159: Indian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 160: Indian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 161: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 162: Indian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 163: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 164: Indian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 165: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 166: Indian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 167: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Japan
Chart 168: Japanese Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 169: Japanese Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 170: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 171: Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 172: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 173: Japanese Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 174: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 175: Japanese Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 176: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Rest of Asia-Pacific
Chart 177: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 178: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 179: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 180: Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 181: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 182: Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 183: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 184: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 185: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
REST OF WORLD
Chart 186: Rest of World Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 187: Rest of World Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 188: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 189: Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 190: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 191: Rest of World Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 192: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 193: Rest of World Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 194: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
1. INTRODUCTION
1.1 Product Outline
1.1.1 An Overview of Atrial Fibrillation
1.1.1.1 Classification of AF
1.1.1.1.1 Paroxysmal (Self-Terminating or Intermittent) Atrial Fibrillation
1.1.1.1.2 Persistent Atrial Fibrillation
1.1.1.1.3 Permanent Atrial Fibrillation
1.1.1.1.4 Lone Atrial Fibrillation
1.1.1.2 Clinical Features
1.1.1.3 Risk factors for Atrial Fibrillation
1.1.1.3.1 Clinical Risk Factors
1.1.1.3.2 Reversible Risk Factors
1.1.1.3.3 Nonmodifiable Factors
1.1.1.3.4 Emerging Risk Factors
1.1.2 Treatment of Atrial Fibrillation (AF)
1.1.2.1 Non-Pharmacological Treatments
1.1.2.1.1 Catheter Ablation
1.1.2.1.2 Electric Cardioversion
1.1.2.1.3 High Intensity Focused Ultrasound (HIFU)
1.1.2.1.4 Maze Surgery
1.1.2.1.5 Other Ablation Treatments
1.1.2.1.5.1 Cryoablation
1.1.2.1.5.2 Microwave Ablation
1.1.2.1.5.3 Radiofrequency Ablation
1.1.2.2 Pharmacological Treatments
1.1.2.2.1 Blood Thinners
1.1.2.2.1.1 Antiplatelet Drugs
1.1.2.2.1.2 Anticoagulants Drugs
1.1.2.2.2 Heart Rate Drugs
1.1.2.2.2.1 Beta-Blockers
1.1.2.2.2.2 Calcium Channel Blockers
1.1.2.2.2.3 Digitalis Glycosides
1.1.2.2.3 Heart Rhythm Drugs
1.1.2.2.3.1 Sodium Channel Blockers
1.1.2.2.3.2 Potassium Channel Blockers
2. AF TREATMENT BY END-USER FACILITIES – MARKET SNAPSHOT
2.1 Ambulatory Surgical Centers
2.2 Cardiac Centers
2.3 Hospitals
3. KEY MARKET TRENDS
3.1 Artificial Intelligence Comes to the Fore in Diagnosing and Managing Arrythmias
3.2 Digital Health Technologies Take a Lead in Screening for Atrial Fibrillation (AF)
3.3 Thumb ECGs Playing a Greater Role Atrial Fibrillation Detection
3.4 Atrial Fibrillation Treated Successfully through Pulsed Field Ablation
3.5 Revolutionary Catheter Ablation Technologies for AF Take Centerstage
4. KEY GLOBAL PLAYERS
Abbott Laboratories (United States)
Atricure, Inc. (United States)
Biosense Webster, Inc. (United States)
Biotronik SE & Co. Kg (Germany)
Boehringer Ingelheim International GmbH (Germany)
Boston Scientific Corporation (United States)
Bristol-Myers Squibb Co. (United States)
Cardiofocus, Inc. (United States)
Cathrx Ltd (Australia)
Medtronic Plc (Ireland)
Osypka AG (Germany)
Pfizer Inc. (United States)
Shanghai Microport Medical (Group) Co Ltd (China)
Siemens Medical Solutions USA, Inc. (United States)
5. KEY BUSINESS & PRODUCT TRENDS
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Acutus Medical’s Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System
Medtronic to Acquire Affera
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation
Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Biosense Webster Announces Completion of Atrial Fibrillation Cases Using Novel HELIOSTAR Balloon Ablation Catheter
New Data & Innovations: Heart Rhythm 2021
BIOTRONIK Expands Range of Peripheral Introducer Sheaths
CardioFocus-Announces-Agreement-to-Acquire-Intellectual-Property-Press-Release.pdf
Late-Breaking Data Shows Abbott's Amplatzer Amulet Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke
Abbott's Amplatzer Amulet Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless Pacemaker
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Abbott Receives European And Canadian Approval For Amplatzer Steerable Delivery Sheath To Optimize Left Atrial Appendage Closure Procedures For People At Risk Of Stroke
Medtronic Receives FDA Expanded Approval for Arctic Front Family of Cardiac Cryoablation Catheters for Initial Use for Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Abbott Introduces Jot Dx Insertable Cardiac Monitor, Designed To Reduce Data Burden And Improve Accurate Diagnosis Of Difficult-To-Detect Abnormal Heart Rhythms
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
New Data & Innovations: Heart Rhythm 2021
BIOTRONIK’s Cardiac Monitor Receives Prestigious Award
Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX Left Atrial Appendage Closure Device
CardioFocus to Exhibit and Present Data Supporting HeartLight X3 System at Heart Rhythm 2021
CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care
Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes
Siemens Healthineers Receives CE Mark for the ACUSON AcuNav Volume ICE Catheter
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate FORCE Sensing Ablation System
Japan Lifeline Finalizes Supply Agreement for Pulsed Electric Field Ablation Catheter for U.S. Market
Acutus Medical Announces FDA Clearance of AcQCross, a Full Suite of Universal Transseptal Crossing Devices
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate FORCE Sensing Ablation System
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
Acutus Medical Receives Vizient Innovative Technology Contract
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
CardioFocus Announces Expanded Partnership With Japan Lifeline
CardioFocus Announces Expanded Distribution Partnership With MicroPort CRM To Include Spain And Portugal
Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation
Acutus Medical Announces CE Mark and European Launch of AcQCross Transseptal System, a Fully Integrated Family of Transseptal Crossing Products
CardioFocus Announces 10,000 Patients Treated Worldwide
First Clinical Implantation of MicroPort Left…
Abbott Introduces Next-Generation 3d Cardiac Mapping Platform In Europe And Australia
The New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy
Acutus Medical Launches AcQBlate Force Sensing Ablation System in Europe
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter
Acutus Medical Announces Pulsed Field Ablation Program and Initial Pre-Clinical Results
Medtronic Gains FDA Clearance, CE Mark for LINQ II Insertable Cardiac Monitor (ICM)
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
Medtronic Micra AV Receives CE Mark
New Alliance Maps the Way in Electrophysiology
CardioFocus Announces US FDA Approval of HeartLight X3 System for the Treatment of Atrial Fibrillation
GE Healthcare and Preventice Solutions Collaborate to Connect the Heart, the Hospital and the Home Seamlessly
Bristol Myers Squibb - The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis
6. GLOBAL MARKET OVERVIEW
6.1 Global Atrial Fibrillation Market Overview by Treatment Type
6.1.1 Global Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
6.1.2 Global Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
6.1.3 Atrial Fibrillation Treatment Type Market Overview by Global Region
6.1.3.1 Non-Pharmacological
6.1.3.1.1 Atrial Fibrillation’s Non-Pharmacological Treatment Sub-Type Market Overview by Global Region
6.1.3.1.1.1 Catheter Ablation
6.1.3.1.1.2 Electric Cardioversion
6.1.3.1.1.3 High Intensity Focused Ultrasound (HIFU)
6.1.3.1.1.4 Maze Surgery
6.1.3.1.1.5 Other Ablation Treatments
6.1.3.2 Pharmacological
6.1.3.2.1 Atrial Fibrillation’s Pharmacological Treatment Sub-Type Market Overview by Global Region
6.1.3.2.1.1 Blood Thinners
6.1.3.2.1.2 Heart Rate Drugs
6.1.3.2.1.3 Heart Rhythm Drugs
6.2 Global Atrial Fibrillation Market Overview by End-User Facility
6.2.1 Atrial Fibrillation End-User Facility Market Overview by Global Region
6.2.1.1 Ambulatory Surgical Centers
6.2.1.2 Cardiac Centers
6.2.1.3 Hospitals
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
7.1 North American Atrial Fibrillation Market Overview by Geographic Region
7.2 North American Atrial Fibrillation Market Overview by Treatment Type
7.2.1 North American Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.2.2 North American Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.3 North American Atrial Fibrillation Market Overview by End-User Facility
7.4 Major Market Players
Abbott Laboratories (United States)
Acutus Medical, Inc. (United States)
Atricure, Inc. (United States)
Biosense Webster, Inc. (United States)
Boston Scientific Corporation (United States)
Bristol-Myers Squibb Co. (United States)
Cardiofocus, Inc. (United States)
GE Healthcare (United States)
Pfizer Inc. (United States)
Siemens Medical Solutions USA, Inc. (United States)
7.5 Country-wise Analysis of North American Atrial Fibrillation Market
7.5.1 The United States
7.5.1.1 United States' Atrial Fibrillation Market Overview by Treatment Type
7.5.1.1.1 United States' Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.1.1.2 United States' Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.1.2 United States' Atrial Fibrillation Market Overview by End-User Facility
7.5.2 Canada
7.5.2.1 Canadian Atrial Fibrillation Market Overview by Treatment Type
7.5.2.1.1 Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.2.1.2 Canadian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.2.2 Canadian Atrial Fibrillation Market Overview by End-User Facility
7.5.3 Mexico
7.5.3.1 Mexican Atrial Fibrillation Market Overview by Treatment Type
7.5.3.1.1 Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
7.5.3.1.2 Mexican Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
7.5.3.2 Mexican Atrial Fibrillation Market Overview by End-User Facility
8. EUROPE
8.1 European Atrial Fibrillation Market Overview by Geographic Region
8.2 European Atrial Fibrillation Market Overview by Treatment Type
8.2.1 European Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.2.2 European Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.3 European Atrial Fibrillation Market Overview by End-User Facility
8.4 Major Market Players
Acesion Pharma (Denmark)
Afreeze GmbH (Austria)
Biotronik SE & Co. Kg (Germany)
Boehringer Ingelheim International GmbH (Germany)
Medtronic PLC (Ireland)
Osypka AG (Germany)
8.5 Country-wise Analysis of European Atrial Fibrillation Market
8.5.1 France
8.5.1.1 French Atrial Fibrillation Market Overview by Treatment Type
8.5.1.1.1 French Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.1.1.2 French Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.1.2 French Atrial Fibrillation Market Overview by End-User Facility
8.5.2 Germany
8.5.2.1 German Atrial Fibrillation Market Overview by Treatment Type
8.5.2.1.1 German Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.2.1.2 German Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.2.2 German Atrial Fibrillation Market Overview by End-User Facility
8.5.3 Italy
8.5.3.1 Italian Atrial Fibrillation Market Overview by Treatment Type
8.5.3.1.1 Italian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.3.1.2 Italian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.3.2 Italian Atrial Fibrillation Market Overview by End-User Facility
8.5.4 The United Kingdom
8.5.4.1 United Kingdom Atrial Fibrillation Market Overview by Treatment Type
8.5.4.1.1 United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.4.1.2 United Kingdom Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.4.2 United Kingdom Atrial Fibrillation Market Overview by End-User Facility
8.5.5 Rest of Europe
8.5.5.1 Rest of Europe Atrial Fibrillation Market Overview by Treatment Type
8.5.5.1.1 Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
8.5.5.1.2 Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
8.5.5.2 Rest of Europe Atrial Fibrillation Market Overview by End-User Facility
9. ASIA-PACIFIC
9.1 Asia-Pacific Atrial Fibrillation Market Overview by Geographic Region
9.2 Asia-Pacific Atrial Fibrillation Market Overview by Treatment Type
9.2.1 Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.2.2 Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.3 Asia-Pacific Atrial Fibrillation Market Overview by End-User Facility
9.4 Major Market Players
Cathrx Ltd (Australia)
Japan Lifeline Co. (Japan)
Shanghai Microport Medical (Group) Co Ltd (China)
9.5 Country-wise Analysis of Asia-Pacific Atrial Fibrillation Market
9.5.1 China
9.5.1.1 Chinese Atrial Fibrillation Market Overview by Treatment Type
9.5.1.1.1 Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.1.1.2 Chinese Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.1.2 Chinese Atrial Fibrillation Market Overview by End-User Facility
9.5.2 India
9.5.2.1 Indian Atrial Fibrillation Market Overview by Treatment Type
9.5.2.1.1 Indian Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.2.1.2 Indian Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.2.2 Indian Atrial Fibrillation Market Overview by End-User Facility
9.5.3 Japan
9.5.3.1 Japanese Atrial Fibrillation Market Overview by Treatment Type
9.5.3.1.1 Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.3.1.2 Japanese Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.3.2 Japanese Atrial Fibrillation Market Overview by End-User Facility
9.5.4 Rest of Asia-Pacific
9.5.4.1 Rest of Asia-Pacific Atrial Fibrillation Market Overview by Treatment Type
9.5.4.1.1 Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
9.5.4.1.2 Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
9.5.4.2 Rest of Asia-Pacific Atrial Fibrillation Market Overview by End-User Facility
10. REST OF WORLD
10.1 Rest of World Atrial Fibrillation Market Overview by Treatment Type
10.1.1 Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Overview by Sub-Type
10.1.2 Rest of World Atrial Fibrillation Pharmacological Treatment Market Overview by Sub-Type
10.2 Rest of World Atrial Fibrillation Market Overview by End-User Facility
PART C: GUIDE TO THE INDUSTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
CHARTS & GRAPHS
PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Atrial Fibrillation Market (2019, 2021, 2022 & 2027) by Geographic Region
Chart 2: Global Non-Pharmacological Treatment of AF Market (2019, 2021, 2022 & 2027) by Sub-Type
Chart 3: Global Pharmacological Treatment of AF Market (2019, 2021, 2022 & 2027) by Sub-Type
Chart 4: Global Atrial Fibrillation Market (2019, 2021, 2022 & 2027) by End-User Facility
Chart 5: Trending of AF Treatment Market (2021 & 2027) in Ambulatory Surgical Centers by Geographic Region
Chart 6: Trending of AF Treatment Market (2021 & 2027) in Cardiac Centers by Geographic Region
Chart 7: Trending of AF Treatment Market (2021 & 2027) in Hospitals by Geographic Region
Chart 8: Global Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 9: Global Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 10: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 11: Global Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 12: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 13: Global Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 14: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 15: Global Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 16: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 17: Global Atrial Fibrillation Catheter Ablation Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 18: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Catheter Ablation Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 19: Global Atrial Fibrillation Electric Cardioversion Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2018, 2021 and 2027 Global Electric Cardioversion Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 21: Global Atrial Fibrillation High Intensity Focused Ultrasound (HIFU) Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2018, 2021 and 2027 Global High Intensity Focused Ultrasound (HIFU) Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 23: Global Atrial Fibrillation Maze Surgery Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2018, 2021 and 2027 Global Maze Surgery Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 25: Global Atrial Fibrillation Other Ablation Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 26: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Other Ablation Treatments Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 27: Global Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Pharmacological Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 29: Global Atrial Fibrillation Blood Thinner Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Blood Thinner Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 31: Global Atrial Fibrillation Heart Rate Drug Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Heart Rate Drug Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 33: Global Atrial Fibrillation Heart Rhythm Drug Treatments Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 34: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Heart Rhythm Drug Treatment Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 35: Global Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 36: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Chart 37: Global Atrial Fibrillation Market Analysis (2018-2027) in Ambulatory Surgical Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 38: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Ambulatory Surgical Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 39: Global Atrial Fibrillation Market Analysis (2018-2027) in Cardiac Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 40: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Cardiac Centers by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 41: Global Atrial Fibrillation Market Analysis (2018-2027) in Hospitals by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 42: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) in Hospitals by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
PART B: REGIONAL MARKET PERSPECTIVE
Chart 43: Global Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 44: Glance at 2018, 2021 and 2027 Global Atrial Fibrillation Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
REGIONAL MARKET OVERVIEW
NORTH AMERICA
Chart 45: North American Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 46: North American Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 47: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 48: North American Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 49: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 50: North American Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 51: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 52: North American Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 53: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 54: North American Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 55: Glance at 2018, 2021 and 2027 North American Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
The United States
Chart 56: United States' Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 57: United States' Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 58: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 59: United States' Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 60: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 61: United States' Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 62: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 63: United States' Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 64: Glance at 2018, 2021 and 2027 United States' Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Canada
Chart 65: Canadian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 66: Canadian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 67: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 68: Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 69: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 70: Canadian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 71: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 72: Canadian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 73: Glance at 2018, 2021 and 2027 Canadian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Mexico
Chart 74: Mexican Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 75: Mexican Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 76: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 77: Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 78: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 79: Mexican Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 80: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 81: Mexican Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 82: Glance at 2018, 2021 and 2027 Mexican Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
EUROPE
Chart 83: European Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 84: European Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
Chart 85: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe
Chart 86: European Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 87: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 88: European Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 89: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 90: European Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 91: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 92: European Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 93: Glance at 2018, 2021 and 2027 European Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
France
Chart 95: French Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 96: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 97: French Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 98: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 99: French Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 100: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 101: French Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 102: Glance at 2018, 2021 and 2027 French Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Germany
Chart 103: German Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 104: German Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 105: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 106: German Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 107: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 108: German Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 109: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 110: German Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 111: Glance at 2018, 2021 and 2027 German Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Italy
Chart 112: Italian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 113: Italian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 114: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 115: Italian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 116: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 117: Italian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 118: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 119: Italian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 120: Glance at 2018, 2021 and 2027 Italian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
The United Kingdom
Chart 121: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 122: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 123: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 124: United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 125: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 126: United Kingdom Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 127: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 128: United Kingdom Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 129: Glance at 2018, 2021 and 2027 United Kingdom Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Rest of Europe
Chart 130: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 131: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 132: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 133: Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 134: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 135: Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 136: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 137: Rest of Europe Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 138: Glance at 2018, 2021 and 2027 Rest of Europe Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
ASIA-PACIFIC
Chart 139: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 140: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Geographic Region – China, India, Japan and Rest of Asia-Pacific in USD Million
Chart 141: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by Geographic Region – China, India, Japan and Rest of Asia-Pacific
Chart 142: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 143: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 144: Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 145: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 146: Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 147: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 148: Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 149: Glance at 2018, 2021 and 2027 Asia-Pacific Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
China
Chart 150: Chinese Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 151: Chinese Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 152: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 153: Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 154: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 155: Chinese Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 156: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 157: Chinese Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 158: Glance at 2018, 2021 and 2027 Chinese Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
India
Chart 159: Indian Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 160: Indian Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 161: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 162: Indian Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 163: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 164: Indian Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 165: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 166: Indian Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 167: Glance at 2018, 2021 and 2027 Indian Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Japan
Chart 168: Japanese Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 169: Japanese Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 170: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 171: Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 172: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 173: Japanese Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 174: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 175: Japanese Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 176: Glance at 2018, 2021 and 2027 Japanese Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
Rest of Asia-Pacific
Chart 177: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 178: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 179: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 180: Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 181: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 182: Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 183: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 184: Rest of Asia-Pacific Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 185: Glance at 2018, 2021 and 2027 Rest of Asia-Pacific Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
REST OF WORLD
Chart 186: Rest of World Atrial Fibrillation Market Analysis (2018-2027) in USD Million
Chart 187: Rest of World Atrial Fibrillation Market Analysis (2018-2027) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment in USD Million
Chart 188: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Market Share (%) by Treatment Type – Non-Pharmacological Treatment and Pharmacological Treatment
Chart 189: Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments in USD Million
Chart 190: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Non-Pharmacological Treatment Market Share (%) by Sub-Type – Catheter Ablation, Electric Cardioversion, High Intensity Focused Ultrasound (HIFU), Maze Surgery and Other Ablation Treatments
Chart 191: Rest of World Atrial Fibrillation Pharmacological Treatment Market Analysis (2018-2027) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs in USD Million
Chart 192: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Pharmacological Treatment Market Share (%) by Sub-Type – Blood Thinners, Heart Rate Drugs and Heart Rhythm Drugs
Chart 193: Rest of World Atrial Fibrillation Market Analysis (2018-2027) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals in USD Million
Chart 194: Glance at 2018, 2021 and 2027 Rest of World Atrial Fibrillation Market Share (%) by End-User Facility – Ambulatory Surgical Centers, Cardiac Centers and Hospitals
